Association of CD14 variant with prostate cancer in African American men
- 14 October 2009
- journal article
- research article
- Published by Wiley in The Prostate
- Vol. 70 (3) , 262-269
Abstract
BACKGROUND: African American men have the highest rates of prostate cancer worldwide, and immunogenetic studies suggest that people of African descent have increased susceptibility to diseases of inflammation. Since genetic susceptibility is an etiological factor in prostate cancer, we hypothesize that sequence variants in the promoter region of the CD14 gene that regulate inflammation may modify individual susceptibility to this disease.METHODS: The CD14 promoter was screened for single‐nucleotide polymorphisms (SNPs) using dHPLC. One variant, −260 C>T (rs2569190), was genotyped via restriction digest in all study participants (264 cases and 188 controls). The association of disease status and the polymorphism was analyzed by unconditional logistic regression. Odds ratios with 95% confidence intervals were calculated, stratifying by ethnicity and adjusting for age. Two‐sided P‐values of ≤0.05 were considered as statistically significant.RESULTS: Eleven variants (four novel) were identified in the promoter region of CD14. A marginal association between the C genotypes (C/C + C/T) and prostate cancer was found (P = 0.07). When stratified by age, among men ≥55 years of age, the C genotypes were significantly associated with prostate cancer (P < 0.05). When stratified by self‐reported ethnicity, African American males who had the C genotypes were at a higher risk for prostate cancer (P < 0.05).CONCLUSIONS: This is the first study to show an association between the C genotypes of the CD14 (−260) variant and prostate cancer which supports the hypothesis that genetic variation in the inflammatory process can contribute to prostate cancer susceptibility in African American men. Prostate 70: 262–269, 2010.Keywords
Funding Information
- National Institutes of Health (S06 GM08016, RR03048)
- Department of Defense (DAMD W81XWH-07-1-0203, DAMD W81XWH-06-1-0066)
This publication has 32 references indexed in Scilit:
- Helminth infections: the great neglected tropical diseasesJournal of Clinical Investigation, 2008
- A cytokine-mediated link between innate immunity, inflammation, and cancerJournal of Clinical Investigation, 2007
- Genetic epidemiology of health disparities in allergy and clinical immunologyJournal of Allergy and Clinical Immunology, 2006
- Changing the paradigm from 'race' to human genome variationNature Genetics, 2004
- Membrane-Anchored CD14 Is Important for Induction of Interleukin-8 by Lipopolysaccharide and Peptidoglycan in Uroepithelial CellsClinical and Vaccine Immunology, 2004
- Interleukin-8 confers androgen-independent growth and migration of LNCaP: differential effects of tyrosine kinases Src and FAKOncogene, 2004
- Human Toll‐Like Receptor 4 Mutations but Not CD14 Polymorphisms Are Associated with an Increased Risk of Gram‐Negative InfectionsThe Journal of Infectious Diseases, 2002
- The Toll receptor family and microbial recognitionTrends in Microbiology, 2000
- Heterotrimeric G proteins physically associated with the lipopolysaccharide receptor CD14 modulate both in vivo and in vitro responses to lipopolysaccharide.Journal of Clinical Investigation, 1998
- IgE and protective immunity to helminth infectionsParasite Immunology, 1993